【ChiCTR2100047181】Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer
ChiCTR2100047181
正在进行
/
/
/
2021-06-10
/
/
thyroid cancer
Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer
Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer
The main objective of the current study is to make a comparison between total thyroidectomy with prophylactic central compartment neck dissection and that without it. It specifically relates to papillary thyroid cancer with clinically negative cervical LN metastasis. The study mainly concentrates on the complications rate and the risk of recurrence of the disease.
非随机对照试验
其它
非随机对照试验
N/A
no fund
/
40
/
2017-06-09
2017-11-09
/
Cases with early thyroid cancer of the papillary type (T1, T2 N0 M0), previously diagnosed with FNAC or histopathological surprise in patients who underwent complete thyroidectomy.；
请登录查看1.Papillary thyroid tumor but unfit for operation, associated with metastasis, associated with clinically positive cervical LNs (central or lateral). 2.Recurrent papillary thyroid tumor, with or without previous thyroid operation. 3.Locally advanced papillary thyroid cancer (T3, T4). 4.Micro papillary thyroid cancer.；
请登录查看self sponsored
/
self sponsored的其他临床试验
- Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer
- Can dermatological tarcolimus 0.1 % ointment be used for treatment of spring catarrh what is its efficacy and safety profile
- EFFECTIVENESS OF DISTANCE INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS IN KHYBER PUKHTUNKHWA, PAKISTAN
埃及Al-Azhar university的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10